Corrigendum to "Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths" [Drug and Alcohol Dependence 84 (1) (2006) 102-113] (DOI:10.1016/j.drugalcdep.2006.01.002)
Type
Journal articlePermalink
https://hdl.handle.net/10161/20019Published Version (Please cite this version)
10.1016/j.drugalcdep.2006.01.018Publication Info
(2007). Corrigendum to "Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam
among American youths" [Drug and Alcohol Dependence 84 (1) (2006) 102-113] (DOI:10.1016/j.drugalcdep.2006.01.002).
Drug and Alcohol Dependence, 86(2-3). pp. 301. 10.1016/j.drugalcdep.2006.01.018. Retrieved from https://hdl.handle.net/10161/20019.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info